References
- Lushnikova I, Orlovsky M, Dosenko V, Maistrenko A, Skibo G. Brief anoxia preconditioning and HIF prolyl-hydroxylase inhibition enhances neuronal resistance in organotypic hippocampal slices on model of ischemic damage. Brain Res 2011;1386:175–83. doi: 10.1016/j.brainres.2011.02.033
- Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 2002;99:11946–50. doi: 10.1073/pnas.182296499
- Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 2005;14:207–21. doi: 10.1159/000088637
- Storkebaum E, Carmeliet P. VEGF: a critical player in neurodegeneration. J Clin Invest 2004;113:14–8. doi: 10.1172/JCI20682
- Sato K, Morimoto N, Kurata T, Mimoto T, Miyazaki K, Ikeda Y, et al. Impaired response of hypoxic sensor protein HIF-1α and its downstream proteins in the spinal motor neurons of ALS model mice. Brain Res 2012;1473:55–62. doi: 10.1016/j.brainres.2012.07.040
- Eskelinen MH, Ngandu T, Tuomilehto J, Soininen H, Kivipelto M. Midlife coffee and tea drinking and the risk of late-life dementia: a population-based CAIDE study. J Alzheimers Dis 2009;16:85–91. doi: 10.3233/JAD-2009-0920
- Santos C, Costa J, Santos J, Vaz-Carneiro A, Lunet N. Caffeine intake and dementia: systematic review and meta-analysis. J Alzheimers Dis 2010;20(1):S187–204. doi: 10.3233/JAD-2010-091387
- You DC, Kim YS, Ha AW, Lee YN, Kim SM, Kim CH, et al. Possible health effects of caffeinated coffee consumption on Alzheimer's disease and cardiovascular disease. Toxicol Res 2011;27:7–10. doi: 10.5487/TR.2011.27.1.007
- Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306–9. doi: 10.1126/science.2479986
- Arendash GW, Cao C. Caffeine and coffee as therapeutics against Alzheimer's disease. J Alzheimers Dis 2010;20(1):S117–126. doi: 10.3233/JAD-2010-091249
- Oboh G, Agunloye OM, Akinyemi AJ, Ademiluyi AO, Adefegha SA. Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats’ brain-in vitro. Neurochem Res 2013;38:413–9. doi: 10.1007/s11064-012-0935-6
- Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 2004;19:176–82. doi: 10.1152/physiol.00001.2004
- Elkins JM, Hewitson KS, McNeill LA, Seibel JF, Schlemminger I, Pugh CW, et al. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha. J Biol Chem 2003;278:1802–6. doi: 10.1074/jbc.C200644200
- Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43–54. doi: 10.1016/S0092-8674(01)00507-4
- Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 2006;46:101–23. doi: 10.1080/10408390500400009
- Banks WA. Characteristics of compounds that cross the blood–brain barrier. BMC Neurol 2009;9(1):S3. doi: 10.1186/1471-2377-9-S1-S3
- Lin LC, Wang MN, Tseng TY, Sung JS, Tsai TH. Pharmacokinetics of (−)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J Agric Food Chem 2007;55:1517–24. doi: 10.1021/jf062816a
- Kaelin WG, Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell, 2008;30:393–402. doi: 10.1016/j.molcel.2008.04.009
- Carru C, Pasciu V, Sotgia S, Zinellu A, Nicoli MC, Deiana L, et al. The oxidative state of LDL is the major determinant of anti/prooxidant effect of coffee on Cu catalysed peroxidation. Open Biochem J 2011;5:1–8. doi: 10.2174/1874091X01105010001
- Vijayalakshmi K, Ostwal P, Sumitha R, Shruthi S, Varghese AM, Mishra P, et al. Role of VEGF and VEGFR2 receptor in reversal of ALS-CSF induced degeneration of NSC-34 motor neuron cell line. Mol Neurobiol 2015;51:995–1007. doi: 10.1007/s12035-014-8757-y
- Herrán E, Requejo C, Ruiz-Ortega JA, Aristieta A, Igartua M, Bengoetxea H, et al. Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease. Int J Nanomed 2014;9:2677–87.